FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

446321003: Denosumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2011. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2879834015 Denosumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2881966015 Denosumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Denosumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Denosumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Denosumab Has disposition Receptor activator of nuclear factor kappa-B ligand inhibitor true Inferred relationship Existential restriction modifier
Denosumab Is a Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely denosumab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Has active ingredient False Denosumab Inferred relationship Existential restriction modifier
Product containing denosumab Has active ingredient True Denosumab Inferred relationship Existential restriction modifier 1
Denosumab therapy Direct substance True Denosumab Inferred relationship Existential restriction modifier 2
Allergy to denosumab Causative agent True Denosumab Inferred relationship Existential restriction modifier 1
Denosumab Has active ingredient True Denosumab Inferred relationship Existential restriction modifier 1
Product containing precisely denosumab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Denosumab Inferred relationship Existential restriction modifier 1
Product containing precisely denosumab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Denosumab Inferred relationship Existential restriction modifier 1
Product containing denosumab in parenteral dose form (medicinal product form) Has active ingredient True Denosumab Inferred relationship Existential restriction modifier 1
Product containing only denosumab in parenteral dose form (medicinal product form) Has active ingredient True Denosumab Inferred relationship Existential restriction modifier 1
Product containing precisely denosumab 70 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Denosumab Inferred relationship Existential restriction modifier 1
Product containing precisely denosumab 70 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Denosumab Inferred relationship Existential restriction modifier 1
Denosumab allergy Causative agent False Denosumab Inferred relationship Existential restriction modifier 1
Denosumab 60mg/1ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Denosumab Inferred relationship Existential restriction modifier
Prolia 60mg/1ml solution for injection pre-filled syringes (Amgen Ltd) 1 pre-filled disposable injection Has specific active ingredient True Denosumab Inferred relationship Existential restriction modifier
Denosumab 60mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Denosumab Inferred relationship Existential restriction modifier
Prolia 60mg/1ml solution for injection pre-filled syringes (Amgen Ltd) Has specific active ingredient True Denosumab Inferred relationship Existential restriction modifier
Denosumab 60mg/1ml solution for injection pre-filled syringes Has active ingredient False Denosumab Inferred relationship Existential restriction modifier
Prolia 60mg/1ml solution for injection pre-filled syringes (Amgen Ltd) Has active ingredient True Denosumab Inferred relationship Existential restriction modifier
Denosumab 120mg/1.7ml solution for injection vials Has active ingredient False Denosumab Inferred relationship Existential restriction modifier
Denosumab 120mg/1.7ml solution for injection vials Has specific active ingredient True Denosumab Inferred relationship Existential restriction modifier
Xgeva 120mg/1.7ml solution for injection vials (Amgen Ltd) Has active ingredient True Denosumab Inferred relationship Existential restriction modifier
Xgeva 120mg/1.7ml solution for injection vials (Amgen Ltd) Has specific active ingredient True Denosumab Inferred relationship Existential restriction modifier
Denosumab 120mg/1.7ml solution for injection vials 1 vial Has specific active ingredient True Denosumab Inferred relationship Existential restriction modifier
Xgeva 120mg/1.7ml solution for injection vials (Amgen Ltd) 1 vial Has specific active ingredient True Denosumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start